Skip to main content
Timothy W. Jacobs, PharmD, BCPPS

Timothy W. Jacobs, PharmD, BCPPS

  • Education Coordinator
  • Assistant Professor, The University of Tennessee Health Sciences Center, Department of Clinical Pharmacy and Translational Science

Board Certification

  • BCPPS

Education

  • BS – Middle Tennessee State University, Murfreesboro, Tennessee
  • PharmD - University of Tennessee College of Pharmacy, Memphis, Tennessee

Post-Graduate Certification

  • Pharmacy Advance Career Training, St. Jude Children’s Research Hospital

Focused Area of Practice

  • Non-malignant hematology
  • Critical Care

Honors/Awards

  • 2020  Clinical Care Improvement Award for Clinical Pharmacy Services, St. Jude Children’s Research Hospital 
  • 2014  Pharmaceutical Department Employee of the Year, St. Jude Children’s Research Hospital 

Research Interests

  • Sickle Cell Disease
  • Hemophilia
  • Aplastic anemia

St. Jude Committee Service

  • Competency and Monitoring Committee (Chair)
  • Harvey Team Committee
  • Accreditation Council for Pharmacy Education Committee (Chair)
  • Continuing Medical Education Committee
  • Residency Advisory Committee

Pharmacy Organizations/Committee Service

  • Children's Oncology Group
  • American Society of Health-System Pharmacists
  • American College of Clinical Pharmacy
  • Pediatric Pharmacy Association (Recertification Committee Co-Chair)
  • Hematology Oncology Pharmacy Association
  • Tennessee Pharmacist Association 

Selected Publications

Drennan CN, Pauley JL, Christensen AM, Jacobs TW, Bragg AW, Porter JP, Bourque MS.  Pharmacist Effect on Discharge Follow-Up Education in Pediatric Oncology Outpatient Clinics: A Quality Improvement Study. The Journal of Pediatric Pharmacology and Therapeutics (2023) 28(3): 262-267. 2023 June 2. doi: 10.5863/1551-6776-28.3.26. PMID: 37303764.

Bolous NS, Chen Y, Wang H, Davidoff AM, Devidas M, Jacobs TW, Meagher MM, Nathwani AC, Neufeld EJ, Piras BA, Rodriguez-Galindo C, Reiss UM, Bhakta N. The Cost-effectiveness of Gene Therapy for Severe Hemophilia B: Microsimulation Study from the United States Perspective. Blood. 2021 Apr 25:blood.2021010864. doi: 10.1182/blood.2021010864. Epub ahead of print. PMID: 33895800.

Lesmana H, Jacobs T, Boals M, Gray N, Lewis S, Ding J, Kang G, Hale M, Weiss M, Reiss U, Wang W, Wlodarski M. Eltrombopag in children with severe aplastic anemia. Pediatr Blood Cancer. 2021 Aug;68(8):e29066. doi: 10.1002/pbc.29066. Epub 2021 Apr 15. PMID: 33855784.

McEneny-King A, Chelle P, Goggans MH, Barker PJ, Jacobs TW, Neufeld EJ, Reiss UM, Panetta JC. Limited sampling strategies for accurate determination of extended half-life factor VIII pharmacokinetics in severe haemophilia A patients. Haemophilia. 2021 May;27(3):408-416. doi: 10.1111/hae.14288. Epub 2021 Mar 20. PMID: 33742733.

Last update: October 2024

Close